Free Shipping Canada-wide on orders over $149.
Free Shipping Canada-wide on orders over $149.
Lab X Peptides stands behind this next-generation triple-agonist peptide with a commitment to uncompromising quality and research integrity. Widely studied in metabolic research, all peptides are sourced through WHO/GMP and ISO 9001:2015 certified manufacturing partners to ensure exceptional purity and consistency. Each batch undergoes rigorous quality control testing to maintain accuracy and reliability for research applications. LabX Peptides prioritizes transparent standards and dependable sourcing so researchers can work with complete confidence.
ARA-290 is a synthetic peptide derived from the tissue-protective region of erythropoietin (EPO). It has been extensively studied in laboratory settings for its interaction with the innate repair receptor (IRR), where researchers investigate its potential role in tissue repair, inflammatory signaling, and peripheral nerve function.
Preclinical and early clinical research has explored ARA-290 across several experimental models involving inflammation, neuropathic pathways, metabolic regulation, and tissue regeneration. Unlike erythropoietin itself, ARA-290 was designed to selectively activate tissue-protective mechanisms without stimulating red blood cell production.
This product is supplied as a high-purity lyophilized peptide intended exclusively for laboratory research and analytical applications.
For laboratory research use only. Not for human consumption.
Orders are processed promptly and shipped through trusted carriers to ensure timely, secure, and dependable delivery.
In stock (300 left)